Home  |  Contact

UniProtKB/Swiss-Prot P00740: Variant p.Ser411Ile

Coagulation factor IX
Gene: F9
Variant information

Variant position:  411
The position of the amino-acid change on the UniProtKB canonical protein sequence.

Type of variant:  LP/P [Disclaimer]
The variants are classified into three categories: LP/P, LB/B and US.
  • LP/P: likely pathogenic or pathogenic.
  • LB/B: likely benign or benign.
  • US: uncertain significance

Residue change:  From Serine (S) to Isoleucine (I) at position 411 (S411I, p.Ser411Ile).
Indicates the amino acid change of the variant. The one-letter and three-letter codes for amino acids used in UniProtKB/Swiss-Prot are those adopted by the commission on Biochemical Nomenclature of the IUPAC-IUB.

Physico-chemical properties:  Change from small size and polar (S) to medium size and hydrophobic (I)
The physico-chemical property of the reference and variant residues and the change implicated.

BLOSUM score:  -2
The score within a Blosum matrix for the corresponding wild-type to variant amino acid change. The log-odds score measures the logarithm for the ratio of the likelihood of two amino acids appearing by chance. The Blosum62 substitution matrix is used. This substitution matrix contains scores for all possible exchanges of one amino acid with another:
  • Lowest score: -4 (low probability of substitution).
  • Highest score: 11 (high probability of substitution).
More information can be found on the following page

Variant description:  In HEMB; Schmallenberg.
Any additional useful information about the variant.

Other resources:  
Links to websites of interest for the variant.



Sequence information

Variant position:  411
The position of the amino-acid change on the UniProtKB canonical protein sequence.

Protein sequence length:  461
The length of the canonical sequence.

Location on the sequence:   YNNMFCAGFHEGGRDSCQGD  S GGPHVTEVEGTSFLTGIISW
The residue change on the sequence. Unless the variant is located at the beginning or at the end of the protein sequence, both residues upstream (20) and downstream (20) of the variant will be shown.

Residue conservation: 
The multiple alignment of the region surrounding the variant against various orthologous sequences.

Human                         YNNMFCAGFHEGGRDSCQGDSGGPHVTEVEGTSFLTGIISW

                              YNNMFCAGFHEGGKDSCQGDSGGPHVTEVEGISFLTGIISW

Chimpanzee                    YNNMFCAGFHEGGRDSCQGDSGGPHVTEVEGTSFLTGIISW

Mouse                         YNNMFCAGYREGGKDSCEGDSGGPHVTEVEGTSFLTGIISW

Rat                           YNNMFCAGYREGGKDSCEGDSGGPHVTEVEGTSFLTGIISW

Bovine                        YSHMFCAGYHEGGKDSCQGDSGGPHVTEVEGTSFLTGIISW

Cat                           YNNMFCAGFHEGGKDSCQGDSGGPHVTEVEGINFLTGIISW

Chicken                       LHSMFCAGYTAGGKDTCGGDSGGPYTNSIGETWFLTGVTSW

Sequence annotation in neighborhood:  
The regions or sites of interest surrounding the variant. In general the features listed are posttranslational modifications, binding sites, enzyme active sites, local secondary structure or other characteristics reported in the cited references. The "Sequence annotation in neighborhood" lines have a fixed format:
  • Type: the type of sequence feature.
  • Positions: endpoints of the sequence feature.
  • Description: contains additional information about the feature.

TypePositionsDescription
Chain 47 – 461 Coagulation factor IX
Chain 227 – 461 Coagulation factor IXa heavy chain
Domain 227 – 459 Peptidase S1
Active site 411 – 411 Charge relay system
Disulfide bond 407 – 435
Mutagenesis 391 – 391 Y -> T. Strongly increases enzyme activity with a synthetic peptide substrate; when associated with F-305; T-311 and A-365.


Literature citations

Hemophilia B caused by five different nondeletion mutations in the protease domain of factor IX.
Ludwig M.; Sabharwal A.K.; Brackmann H.H.; Olek K.; Smith K.J.; Birktoft J.J.; Bajaj S.P.;
Blood 79:1225-1232(1992)
Cited for: VARIANTS HEMB VAL-291; GLN-294; HIS-410; GLY-411 AND ILE-411;

Disclaimer: Any medical or genetic information present in this entry is provided for research, educational and informational purposes only. They are not in any way intended to be used as a substitute for professional medical advice, diagnostic, treatment or care.